Charles River Laboratories International Inc (CRL):企業の財務・戦略的SWOT分析

◆英語タイトル:Charles River Laboratories International Inc (CRL) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15773
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:58
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,625見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Charles River Laboratories International Inc (CRL) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Charles River Laboratories International Inc (Charles River) is a contract research organization (CRO) that provides essential products and services to accelerate the research, drug discovery and development. It offers various basic research, drug discovery and safety assessment services. The organization also offers clinical, manufacturing and operations and staffing support. It focuses on providing solutions targeted against therapeutic areas of cardiovascular, central nervous system, metabolic inflammation, oncology, ophthalmology, respiratory disease and musculoskeletal disease. Charles River caters products and services to pharmaceutical and biotechnology companies, government agencies, as well as leading hospitals and academic institutions. It operates through a network facilities located worldwide. Charles River is headquartered in Wilmington, Massachusetts, the US.

Charles River Laboratories International Inc Key Recent Developments

Apr 02,2019 S derberg & Partners Selects Charles River IMS to Streamline and Consolidate Investment Management Processes
Mar 21,2019 Charles River to Provide Scalable, Enterprise-Wide Operational Support Solution for Morningstar s Investment Management Group
Mar 15,2019 Distributed Bio Enters Into Exclusive Partnership With Charles River Laboratories
Mar 12,2019 Crown Bioscience, Charles River Enter Agreement to Expand Access to ZDSD Rat Model

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Charles River Laboratories International Inc – Key Facts
Charles River Laboratories International Inc – Key Employees
Charles River Laboratories International Inc – Key Employee Biographies
Charles River Laboratories International Inc – Major Products and Services
Charles River Laboratories International Inc – History
Charles River Laboratories International Inc – Company Statement
Charles River Laboratories International Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Charles River Laboratories International Inc – Business Description
Business Segment: Discovery and Safety Assessment
Overview
Performance
Business Segment: Manufacturing Support
Overview
Performance
Business Segment: Research Models and Services
Overview
Performance
Geographical Segment: Asia Pacific
Target Markets
Performance
Geographical Segment: Canada
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Other
Target Markets
Performance
Geographical Segment: US
Performance
Charles River Laboratories International Inc – Corporate Strategy
Charles River Laboratories International Inc – SWOT Analysis
SWOT Analysis – Overview
Charles River Laboratories International Inc – Strengths
Charles River Laboratories International Inc – Weaknesses
Charles River Laboratories International Inc – Opportunities
Charles River Laboratories International Inc – Threats
Charles River Laboratories International Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Charles River Laboratories International Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 02, 2019: S derberg & Partners Selects Charles River IMS to Streamline and Consolidate Investment Management Processes
Mar 21, 2019: Charles River to Provide Scalable, Enterprise-Wide Operational Support Solution for Morningstar s Investment Management Group
Mar 15, 2019: Distributed Bio Enters Into Exclusive Partnership With Charles River Laboratories
Mar 12, 2019: Crown Bioscience, Charles River Enter Agreement to Expand Access to ZDSD Rat Model
Feb 13, 2019: Charles River Laboratories announces fourthQuarter and fullYear 2018 results and provides 2019 guidance
Jan 30, 2019: Charles River Laboratories and Toxys Enter Agreement to Offer ToxTracker&174; in North America
Jan 11, 2019: Charles River Atomwise collaborate on AIdriven drug discovery
Jan 11, 2019: Charles River Laboratories and Atomwise Form a Strategic Alliance to Provide Integrated, Artificial Intelligence-Driven Drug Discovery
Nov 19, 2018: Charles River Associates Expands Insurance Economics Consulting Practice
Nov 13, 2018: Charles River Laboratories continues commitment to Oncology drug discovery
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Charles River Laboratories International Inc, Key Facts
Charles River Laboratories International Inc, Key Employees
Charles River Laboratories International Inc, Key Employee Biographies
Charles River Laboratories International Inc, Major Products and Services
Charles River Laboratories International Inc, History
Charles River Laboratories International Inc, Subsidiaries
Charles River Laboratories International Inc, Key Competitors
Charles River Laboratories International Inc, Ratios based on current share price
Charles River Laboratories International Inc, Annual Ratios
Charles River Laboratories International Inc, Annual Ratios (Cont...1)
Charles River Laboratories International Inc, Annual Ratios (Cont...2)
Charles River Laboratories International Inc, Interim Ratios
Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Charles River Laboratories International Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Charles River Laboratories International Inc, Performance Chart (2014 - 2018)
Charles River Laboratories International Inc, Ratio Charts
Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Charles River Laboratories International Inc (CRL):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ai2 Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Ai2 Limited Mergers and Acquisi …
  • Egyptian General Petroleum Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary Egyptian General Petroleum Corp (EGPC), formerly General Petroleum Authority, is engaged in the oil and gas exploration services. The company is engaged in the refining, production, drilling, transportation and storage of crude oil; production of lubricants and greases; provides man power su …
  • Magenta Therapeutics Inc (MGTA):製薬・医療:M&Aディール及び事業提携情報
    Summary Magenta Therapeutics Inc (Magenta Therapeutics) formerly HSCTCo Therapeutics Inc, is a clinical-stage biotechnology company focused on developing novel medicines which revolutionizes bone marrow transplant for treating autoimmune diseases, blood cancers and rare genetic diseases. Its product …
  • Team Health Holdings Inc-製薬・医療分野:企業M&A・提携分析
    Summary Team Health Holdings Inc (TeamHealth) is a healthcare organization that offers patient care services. The organization’s practice areas include emergency medicine, anesthesiology, hospital medicine, hospital medicine subspecialties, ambulatory care, post-acute care and behavioral health serv …
  • Shanghai Pudong Development Bank Company Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Shanghai Pudong Development Ban …
  • Guardant Health Inc:企業のM&A・提携動向(医療機器分野)
    Summary Guardant Health Inc (Guardant Health) offers non-invasive cancer diagnostics and commercializes genomic liquid biopsies. The company’s proprietary digital sequencing technology is used to detect individual genomic alterations, the reason for the growth of tumors. Guardian Health offers, Guar …
  • Windreich AG:企業のM&A・提携動向(エネルギー分野)
    Summary Windreich AG (Windreich), formerly FC Holding Gmbh is an alternative energy company that designs, develops, builds, operates, finances and sells the wind turbines. The company also carries out the technical and commercial operation of the turbines. Windreich operates wind turbines in both of …
  • Biocartis SA:企業のM&A・提携動向(医療機器分野)
    Summary Biocartis SA (Biocartis) is a molecular diagnostics company that provides personalized medicine for patients through its molecular diagnostics. The company undertakes the development of diagnostics technology platforms for multiplexed detection of bio-analytes, with oncology as its key focus …
  • UltraTech Cement Ltd:企業の戦略・SWOT・財務情報
    UltraTech Cement Ltd - Strategy, SWOT and Corporate Finance Report Summary UltraTech Cement Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Hemispherx Biopharma Inc (HEB):医療機器:M&Aディール及び事業提携情報
    Summary Hemispherx Biopharma Inc (Hemispherx) is a biopharmaceutical company, which develops, manufactures and commercializes drug therapies for the treatments of viral and immune based chronic disorders. It offers products for the treatment of various diseases such as hepatitis B, hepatitis C, chro …
  • CommInsure:企業の戦略・SWOT・財務情報
    CommInsure - Strategy, SWOT and Corporate Finance Report Summary CommInsure - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Campbell Soup Company:企業の戦略・SWOT・財務情報
    Campbell Soup Company - Strategy, SWOT and Corporate Finance Report Summary Campbell Soup Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Consolidated Edison Development Inc:電力:M&Aディール及び事業提携情報
    Summary Consolidated Edison Development Inc (CED), a subsidiary of Consolidated Edison Inc, is an energy company that develops, owns and operates renewable and energy infrastructure projects. The company operates solar photovoltaic projects and wind farms. It operates energy storage and energy pipel …
  • MGM Resorts International:企業の戦略・SWOT・財務分析
    SummaryMGM Resorts International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. K …
  • Mullen Group, Ltd. (formerly Mullen Group Income Fund):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Mullen Group, Ltd. (formerly Mu …
  • PetroTal Corp (TAL):石油・ガス:M&Aディール及び事業提携情報
    Summary PetroTal Corp (PetroTal), formerly known as Sterling Resources Ltd, is an oil and gas company that offers exploration, development and production of crude oil and natural gas properties. The company primarily operates in Bretana oil field in Peru, South America. PetroTal has operations in th …
  • Cox and Kings Limited:企業の戦略・SWOT・財務分析
    SummaryCox and Kings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key F …
  • LycoRed Ltd:企業の戦略・SWOT・財務分析
    SummaryLycoRed Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - …
  • Perry Ellis International, Inc.:企業のM&A・提携・投資分析
    Perry Ellis International, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Perry Ellis International, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Kowa Pharmaceuticals America, Inc., (formerly ProEthic Pharmaceuticals, Inc.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Kowa Pharmaceuticals America, I …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆